TORL BioTherapeutics News and Activities

Acquisition, funding and merger involving TORL BioTherapeutics.

• TORL BioTherapeutics has just announced a $96 Million fundraising (posted on October 13 2025).

View the org chart displaying its 26 main executives

Most searched biographies at TORL BioTherapeutics

• Aran Maree, Chief Executive Officer and Director
• Skip Burris, Director
• Mark Alles, Chairman of the Board

Popular executive movements at TORL BioTherapeutics

• Aran Maree, who was Chief Medical Officer, is promoted to Chief Executive Officer and Director  (posted on May 8 2026).
• Mark Alles who was Chief Executive Officer and Chairman of the Board, becomes Chairman of the Board  (posted on May 8 2026).
• Tracey Marantal has joined the company as Senior Vice President, Clinical Operations  (posted on February 24 2026).

Click here to view some more movements at TORL BioTherapeutics

Create your alert
to follow the executive moves at TORL BioTherapeutics.

TORL BioTherapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by TORL BioTherapeutics

Social media about TORL BioTherapeutics

• TORL BioTherapeutics on Wikipedia, Google News & Yahoo Finance
• TORL BioTherapeutics on LinkedIn, X (Twitter) & YouTube